Genetic heterogeneity of cytogenetically normal AML with mutations of

about

Genetic heterogeneity of cytogenetically normal AML with mutations of

Item

http://www.wikidata.org/entity/Q57795864

description

scientific article published on 01 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Genetic heterogeneity of cytogenetically normal AML with mutations of

@en

Genetic heterogeneity of cytogenetically normal AML with mutations of

@nl

type

Item

label

Genetic heterogeneity of cytogenetically normal AML with mutations of

@en

Genetic heterogeneity of cytogenetically normal AML with mutations of

@nl

prefLabel

Genetic heterogeneity of cytogenetically normal AML with mutations of

@en

Genetic heterogeneity of cytogenetically normal AML with mutations of

@nl

P1476

Genetic heterogeneity of cytogenetically normal AML with mutations of CEBPA

@en

P2093

Annika Dufour

http://www.w3.org/2001/XMLSchema#string

Bernhard J Woermann

http://www.w3.org/2001/XMLSchema#string

Bianka Ksienzyk

http://www.w3.org/2001/XMLSchema#string

Friederike Pastore

http://www.w3.org/2001/XMLSchema#string

Hanns-Georg Klein

http://www.w3.org/2001/XMLSchema#string

Jan Braess

http://www.w3.org/2001/XMLSchema#string

Karsten Spiekermann

http://www.w3.org/2001/XMLSchema#string

Maja Rothenberg-Thurley

http://www.w3.org/2001/XMLSchema#string

Maria C Sauerland

http://www.w3.org/2001/XMLSchema#string

Nikola P Konstandin

http://www.w3.org/2001/XMLSchema#string

P2860

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies

CEBPA mutations in younger adults with acute myeloid leukemia and normal cytogenetics: prognostic relevance and analysis of cooperating mutations.

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

TET2 mutations improve the new European LeukemiaNet risk classification of acute myeloid leukemia: a Cancer and Leukemia Group B study.

TET2 mutations in acute myeloid leukemia (AML): results from a comprehensive genetic and clinical analysis of the AML study group.

The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia.

Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia.

CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia.

P304

2724-2731

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOODADVANCES.2018016840

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2018-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30337300

http://www.w3.org/2001/XMLSchema#string

P932

6199648

http://www.w3.org/2001/XMLSchema#string